BioLineRx

BLRX

#10049

Rank

$11.23 M

Marketcap

🇮🇱 Israel

Country

$2.75

Share price

13.17%

Change (1 day)

281.94%

Change (1 year)

💊 Pharmaceuticals 🧬 Biotech

Annual Reports (20-F)

Latest form 20-F annual reports for BioLineRx CIK: 0001498403
The 20-F is a 10-K equivalent for non-US companies, as a foreight company BioLineRx only files 20-F reports

20-F Annual Report 2024

Language: English

View Annual Report (20-F)

20-F Annual Report 2023

Language: English

View Annual Report (20-F)

20-F Annual Report 2022

Language: English

View Annual Report (20-F)

20-F Annual Report 2021

Language: English

View Annual Report (20-F)

20-F Annual Report 2020

Language: English

View Annual Report (20-F)

20-F Annual Report 2019

Language: English

View Annual Report (20-F)

20-F Annual Report 2018

Language: English

View Annual Report (20-F)

20-F Annual Report 2017

Language: English

View Annual Report (20-F)

20-F Annual Report 2017-03-23

Language: English

View Annual Report (20-F)

20-F Annual Report 2016-03-10

Language: English

View Annual Report (20-F)

20-F Annual Report 2015-03-23

Language: English

View Annual Report (20-F)

20-F Annual Report 2014-03-17

Language: English

View Annual Report (20-F)

20-F Annual Report 2013-03-12

Language: English

View Annual Report (20-F)

20-F Annual Report 2012-03-22

Language: English

View Annual Report (20-F)

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions